Young consumers show skepticism toward GLP-1 drugs, gravitate to wearables
Analysis of 1,400 Gen Next respondents reveals loyalty to Apple Watch and Oura, while skepticism grows around weight-loss medications
Cafeteria released findings from conversations with 1,400 young consumers about health and wellness spending, trust patterns, and product perception. The interactive report compiled 240 hours of in-app private text and voice notes designed to surface which health and wellness categories resonate with younger demographics and which attract skepticism.
The research surfaced meaningful generational divides in health technology adoption. While GLP-1 drugs command significant cultural attention, young consumers express measured hesitation about the category. Wearable devices, by contrast, show stronger attachment among the demographic, with Apple Watch and Oura cited as products generating consistent loyalty rather than perceived as temporary trends.
Cafeteria's methodology centered on capturing unfiltered consumer sentiment through voluntary contributions rather than traditional survey mechanics. The platform compiled these notes across multiple inputs to identify patterns in spending behavior, brand trust, and product perception. Respondents indicated which products began to feel like scams—a metric the company characterized as revealing authentic skepticism rather than passing criticism.
The findings carry implications for health and wellness brands positioning products to younger audiences. Companies backing GLP-1 therapeutics face a consumer segment that remains unconvinced of category durability, while device manufacturers benefiting from established use cases maintain stronger positioning. The data suggests that perception gaps between cultural momentum and actual consumer adoption may be wider than previously measured.
Cafeteria positions itself as a consumer intelligence platform built to capture Gen Next sentiment through ongoing conversation rather than point-in-time surveys. The company did not disclose whether additional findings from the 1,400-person cohort would be released or whether similar research efforts were planned.
The research underscores how luxury and health technology markets increasingly depend on generational trust metrics rather than product specifications alone, particularly as younger consumers develop distinct purchasing rationales from established wealth demographics.